Skip to content
CLINICAL TRIALS

Advancing Research in DNA Medicine

INOVIO is committed to developing new, innovative medicines to fight HPV-related diseases, cancer and infectious diseases. Our goal is to deliver on the promise of DNA medicines for patients around the globe. For more information about our clinical trials, please email .

TITLE PROGRAM PHASE RECRUITING

INO-5401 Vaccination in BRCA1/​2 Mutation Carriers

MORE INFORMATION →
PROGRAM INO-5401
PHASE Phase 1
RECRUITING No

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

MORE INFORMATION →
PROGRAM VGX-3100
PHASE Phase 2
RECRUITING No

VGX-3100 for Patients with Cervical Dysplasia in China (ApolloBio)

PROGRAM VGX-3100
PHASE Phase 3
RECRUITING No